This study characterized SD inhibitory properties of fenfluramine, a serotonin releasing agent, using in vitro SD assays. Our results suggest that fenfluramine can inhibit SD independent of the serotonin system.</p
Assessment of serotonin release in the living brain with positron emission tomography (PET) may have...
Dexfenfluramine, a drug used as an appetite suppressant in Europe, is currently under evaluation for...
[F-18]MPPF is a selective and reversible antagonist to the serotonin-1A (5-HT1A) receptor. The aim o...
The discriminative stimulus properties of fenfluramine: evidence for serotonergic involvement
International audienceThe now-banned anorectic molecule, dexfenfluramine, promotes serotonin release...
The now-banned anorectic molecule, dexfenfluramine, promotes serotonin release through a serotonin t...
AbstractThe purpose of this investigation was to verify the role of dopamine and serotonin receptors...
United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH Na...
This study compared the effects of fenfluramine and fluoxetine on the differential-reinforcement-of-...
The first drug to be found useful in suppressing appetite was amphetamine (Lesser and Meyerson, 1938...
Dexfenfluramine, the therapeutically active dextro-rotatory stereoisomer of fenfluramine, is a serot...
[F-18]MPPF is a selective serotonin-1A (5-HT1A) receptor antagonist and may be used to measure chang...
In humans and other organisms, monoaminergic systems are crucial in neuronal function and behavior. ...
[F-18]MPPF is a selective serotonin-1A (5-HT1A) receptor antagonist and may be used to measure chang...
[F-18]MPPF is a selective and reversible antagonist to the serotonin-1A (5-HT1A) receptor. The aim o...
Assessment of serotonin release in the living brain with positron emission tomography (PET) may have...
Dexfenfluramine, a drug used as an appetite suppressant in Europe, is currently under evaluation for...
[F-18]MPPF is a selective and reversible antagonist to the serotonin-1A (5-HT1A) receptor. The aim o...
The discriminative stimulus properties of fenfluramine: evidence for serotonergic involvement
International audienceThe now-banned anorectic molecule, dexfenfluramine, promotes serotonin release...
The now-banned anorectic molecule, dexfenfluramine, promotes serotonin release through a serotonin t...
AbstractThe purpose of this investigation was to verify the role of dopamine and serotonin receptors...
United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH Na...
This study compared the effects of fenfluramine and fluoxetine on the differential-reinforcement-of-...
The first drug to be found useful in suppressing appetite was amphetamine (Lesser and Meyerson, 1938...
Dexfenfluramine, the therapeutically active dextro-rotatory stereoisomer of fenfluramine, is a serot...
[F-18]MPPF is a selective serotonin-1A (5-HT1A) receptor antagonist and may be used to measure chang...
In humans and other organisms, monoaminergic systems are crucial in neuronal function and behavior. ...
[F-18]MPPF is a selective serotonin-1A (5-HT1A) receptor antagonist and may be used to measure chang...
[F-18]MPPF is a selective and reversible antagonist to the serotonin-1A (5-HT1A) receptor. The aim o...
Assessment of serotonin release in the living brain with positron emission tomography (PET) may have...
Dexfenfluramine, a drug used as an appetite suppressant in Europe, is currently under evaluation for...
[F-18]MPPF is a selective and reversible antagonist to the serotonin-1A (5-HT1A) receptor. The aim o...
DOI
Add to ORKG